Chemokine control of West Nile virus infection.

[1]  Christopher J. Obara,et al.  Chemokine Receptor Ccr2 Is Critical for Monocyte Accumulation and Survival in West Nile Virus Encephalitis , 2011, The Journal of Immunology.

[2]  Ruth R. Montgomery,et al.  A paradoxical role for neutrophils in the pathogenesis of West Nile virus. , 2010, The Journal of infectious diseases.

[3]  D. Follmann,et al.  CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. , 2010, The Journal of infectious diseases.

[4]  J. Wagner,et al.  WEST NILE VIRUS : Epidemiology and Clinical Features of an Emerging Epidemic in the United States ∗ , 2010 .

[5]  N. Van Rooijen,et al.  Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis , 2008, The Journal of experimental medicine.

[6]  M. Diamond,et al.  CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis , 2008, Proceedings of the National Academy of Sciences.

[7]  E. Pamer,et al.  Additive Roles for MCP-1 and MCP-3 in CCR2-Mediated Recruitment of Inflammatory Monocytes during Listeria monocytogenes Infection1 , 2008, The Journal of Immunology.

[8]  M. Diamond,et al.  CXCR3 Mediates Region-Specific Antiviral T Cell Trafficking within the Central Nervous System during West Nile Virus Encephalitis1 , 2008, The Journal of Immunology.

[9]  C. Jean,et al.  Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. , 2008, The Journal of infectious diseases.

[10]  M. Mack,et al.  Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. , 2007, The Journal of clinical investigation.

[11]  F. Tacke,et al.  Migratory fate and differentiation of blood monocyte subsets. , 2006, Immunobiology.

[12]  D. McDermott,et al.  CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection. , 2006, Trends in immunology.

[13]  E. Pamer,et al.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 , 2006, Nature Immunology.

[14]  D. McDermott,et al.  CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.

[15]  M. Diamond,et al.  West Nile Virus from Infected Neurons T Cells Require Perforin to Clear + Cd8 , 2022 .

[16]  D. Link,et al.  G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. , 2005, Blood.

[17]  D. Link,et al.  AMD 3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism , 2006 .

[18]  R. Cholera,et al.  Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection , 2005, The Journal of experimental medicine.

[19]  M. Diamond,et al.  Neuronal CXCL10 Directs CD8+ T-Cell Recruitment and Control of West Nile Virus Encephalitis , 2005, Journal of Virology.

[20]  D. Ben-Nathan,et al.  West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice , 2005, Archives of Virology.

[21]  T. Mizutani,et al.  Different chemokine expression in lethal and non‐lethal murine west nile virus infection , 2004, Journal of medical virology.

[22]  M. McElrath,et al.  Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. , 2004, The Journal of infectious diseases.

[23]  B. Wood,et al.  Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist. , 2004, Supportive cancer therapy.

[24]  J. Goedert,et al.  MCP-1-MCP-3–Eotaxin gene cluster influences HIV-1 transmission , 2003, AIDS.

[25]  R. Prayson,et al.  The Neuropathology of West Nile Virus Meningoencephalitis , 2003 .

[26]  R. Prayson,et al.  The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. , 2003, American journal of clinical pathology.

[27]  J. Flynn,et al.  Mycobacterium tuberculosis in Chemokine Receptor 2-Deficient Mice: Influence of Dose on Disease Progression , 2002, Infection and Immunity.

[28]  B. Rovin,et al.  HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Flynn,et al.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Detels,et al.  Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study , 2000, AIDS.

[31]  M. Olszewski,et al.  Leukocyte recruitment during pulmonary Cryptococcus neoformans infection. , 2000, Immunopharmacology.

[32]  C. Ambrosi,et al.  The pathology of human West Nile Virus infection. , 2000, Human pathology.

[33]  W. Kuziel,et al.  CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.

[34]  George Whyte-Melville,et al.  Good for nothing , 1890 .